TY - JOUR
T1 - Multidrug-resistant commensal Escherichia coli in children, Peru and Bolivia
AU - Bartoloni, Alessandro
AU - Pallecchi, Lucia
AU - Benedetti, Marta
AU - Fernandez, Connie
AU - Vallejos, Yolanda
AU - Guzman, Elisa
AU - Villagran, Ana Liz
AU - Mantella, Antonia
AU - Lucchetti, Chiara
AU - Bartalesi, Filippo
AU - Strohmeyer, Marianne
AU - Bechini, Angela
AU - Gamboa, Herlan
AU - Rodríguez, Hugo
AU - Falkenberg, Torkel
AU - Kronvall, Göran
AU - Gotuzzo, Eduardo
AU - Paradisi, Franco
AU - Rossolini, Gian Maria
PY - 2006
Y1 - 2006
N2 - Using a rapid screening method, we investigated the prevalence in fecal carriage of antimicrobial drug-resistant Escherichia coli in 3,174 healthy children from 4 urban settings in Peru and Bolivia. High resistance rates were observed for ampicillin (95%), trimethoprim-sulfamethoxazole (94%), tetracycline (93%), streptomycin (82%), and chloramphenicol (70%). Lower resistance rates were observed for nalidixic acid (35%), kanamycin (28%), gentamicin (21%), and ciprofloxacin (18%); resistance to ceftriaxone and amikacin was uncommon (TEM, tet(A), tet(B), drfA8, sul1, sul2, and catI. These findings underscore the magnitude of the problem of antimicrobial drug resistance in low-resource settings and the urgent need for surveillance and control of this phenomenon.
AB - Using a rapid screening method, we investigated the prevalence in fecal carriage of antimicrobial drug-resistant Escherichia coli in 3,174 healthy children from 4 urban settings in Peru and Bolivia. High resistance rates were observed for ampicillin (95%), trimethoprim-sulfamethoxazole (94%), tetracycline (93%), streptomycin (82%), and chloramphenicol (70%). Lower resistance rates were observed for nalidixic acid (35%), kanamycin (28%), gentamicin (21%), and ciprofloxacin (18%); resistance to ceftriaxone and amikacin was uncommon (TEM, tet(A), tet(B), drfA8, sul1, sul2, and catI. These findings underscore the magnitude of the problem of antimicrobial drug resistance in low-resource settings and the urgent need for surveillance and control of this phenomenon.
UR - http://www.scopus.com/inward/record.url?scp=33744927441&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33744927441&partnerID=8YFLogxK
M3 - Article
C2 - 16707045
AN - SCOPUS:33744927441
VL - 12
SP - 907
EP - 913
JO - Emerging Infectious Diseases
JF - Emerging Infectious Diseases
SN - 1080-6040
IS - 6
ER -